San Diego 2nd in genomics, study finds – The San Diego Union … – The San Diego Union-Tribune

San Diego County is the nations second-leading center for genomics research and products, according to a study released Monday by the San Diego Regional Economic Development Corp.

The genomics industry contributes $5.6 billion annually to the countys economy, directly creating more than 10,000 jobs, the report said.

The complete study will be available at sandiegobusiness.org/research-center. Its release coincides with the opening of the 2017 convention by BIO, the nations biotechnology trade association, at the San Diego Convention Center.

Boston narrowly edged out San Diego and third-place San Francisco Bay Area for the top spot, according to EDC research director Kirby Brady. Boston prevailed because of the presence of large pharmaceutical companies and top research organizations such as the Broad Institute, she said.

San Diegos life sciences industry is younger than that of the Bay Area and Boston, she said, so the regions life science infrastructure has had less time to mature. But the countys strengths make up for that relative youth, she said.

To quantify the rankings, the report used objective data as research and venture capital funding, genomics patents and the number of graduates with a genomics education.

San Diego County ranked first in the number of genomics patents, with 371 issued from 2014 to 2016. It also ranked first in the number of genomics-ready graduates, relative to the size of its workforce.

Its educational institutions also grant the most degrees in biochemistry, cognitive science and bioinformatics, the report stated. An average of 1,968 genomics-related degrees are conferred.

Companies located in the county, home to about 1 percent of the American population, received 22 percent of venture capital funding for genomics in 2016, the report found.

San Diegos genomics industry had the advantage of strong local genomics programs in every step of the product chain, Brady said. This begins at basic research at local academic centers to clinical collaborators and ultimately leads to genomics powerhouses such as Illumina in San Diego and Thermo Fisher Scientific in Carlsbad.

What that really means in terms of having all those players in the ecosystem here and the collaboration that we see among these players is that youre able to pioneer these discoveries, license intellectual property, bring these new therapies to market faster in many instances, she said.

The ties work in research as well. Human Longevity, a La Jolla company co-founded by genomics pioneer J. Craig Venter, performs much of its genomic work with Illumina sequencers. And Illumina can discuss how the sequencers perform with Human Longevity.

The difficult task of turning research into commercially friendly products is eased by such groups as the Scripps Translational Science Institute, which span research to commercial partners, she said.

The countys ethnic diversity brings a genetic diversity that also benefits the industry, Brady said. It provides a nearby population that can be included in research and clinical development to ensure that products target the needs of the whole population.

bradley.fikes@sduniontribune.com

(619) 293-1020

Link:
San Diego 2nd in genomics, study finds - The San Diego Union ... - The San Diego Union-Tribune